WO2001009332A3 - Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof - Google Patents

Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof Download PDF

Info

Publication number
WO2001009332A3
WO2001009332A3 PCT/EP2000/007294 EP0007294W WO0109332A3 WO 2001009332 A3 WO2001009332 A3 WO 2001009332A3 EP 0007294 W EP0007294 W EP 0007294W WO 0109332 A3 WO0109332 A3 WO 0109332A3
Authority
WO
WIPO (PCT)
Prior art keywords
moraxella catarrhalis
polypeptides derived
immunogenic polypeptides
polypeptides
basb115
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2000/007294
Other languages
French (fr)
Other versions
WO2001009332A2 (en
Inventor
Joelle Thonnard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE60039303T priority Critical patent/DE60039303D1/en
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to EP00956339A priority patent/EP1204752B1/en
Priority to DK00956339T priority patent/DK1204752T3/en
Priority to HK02107743.3A priority patent/HK1047954A1/en
Priority to US10/048,574 priority patent/US7632516B1/en
Priority to AU68323/00A priority patent/AU6832300A/en
Priority to JP2001514124A priority patent/JP2003506043A/en
Priority to CA002380515A priority patent/CA2380515A1/en
Publication of WO2001009332A2 publication Critical patent/WO2001009332A2/en
Publication of WO2001009332A3 publication Critical patent/WO2001009332A3/en
Anticipated expiration legal-status Critical
Priority to US12/621,426 priority patent/US20100075378A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention provides BASB115 polypeptides and polynucleotides encoding BASB115 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
PCT/EP2000/007294 1999-07-30 2000-07-27 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof Ceased WO2001009332A2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CA002380515A CA2380515A1 (en) 1999-07-30 2000-07-27 Polypeptides and polynucleotides from moraxella catarrhalis
EP00956339A EP1204752B1 (en) 1999-07-30 2000-07-27 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof
DK00956339T DK1204752T3 (en) 1999-07-30 2000-07-27 Immunogenic polypeptides derived from Moraxella catarrhalis and their applications
HK02107743.3A HK1047954A1 (en) 1999-07-30 2000-07-27 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof
US10/048,574 US7632516B1 (en) 1999-07-30 2000-07-27 Moraxella catarrhalis BASB115 polypeptides
DE60039303T DE60039303D1 (en) 1999-07-30 2000-07-27 IMMUNOGENOUS POLYPEPTIDES FROM MORAXELLA CATARRHALIS AND ITS USES
JP2001514124A JP2003506043A (en) 1999-07-30 2000-07-27 New compound
AU68323/00A AU6832300A (en) 1999-07-30 2000-07-27 Novel compounds
US12/621,426 US20100075378A1 (en) 1999-07-30 2009-11-18 Moraxella catarrhalis basb115 polypeptides

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9918003.6 1999-07-30
GBGB9918003.6A GB9918003D0 (en) 1999-07-30 1999-07-30 Novel compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/621,426 Division US20100075378A1 (en) 1999-07-30 2009-11-18 Moraxella catarrhalis basb115 polypeptides

Publications (2)

Publication Number Publication Date
WO2001009332A2 WO2001009332A2 (en) 2001-02-08
WO2001009332A3 true WO2001009332A3 (en) 2001-03-22

Family

ID=10858292

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/007294 Ceased WO2001009332A2 (en) 1999-07-30 2000-07-27 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof

Country Status (15)

Country Link
US (2) US7632516B1 (en)
EP (1) EP1204752B1 (en)
JP (1) JP2003506043A (en)
CN (1) CN1378597A (en)
AT (1) ATE399205T1 (en)
AU (1) AU6832300A (en)
CA (1) CA2380515A1 (en)
CY (1) CY1108554T1 (en)
DE (1) DE60039303D1 (en)
DK (1) DK1204752T3 (en)
ES (1) ES2306668T3 (en)
GB (1) GB9918003D0 (en)
HK (1) HK1047954A1 (en)
PT (1) PT1204752E (en)
WO (1) WO2001009332A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9047254B1 (en) 2012-07-05 2015-06-02 Google Inc. Detection and validation of expansion types of expandable content items
TWI887339B (en) 2020-01-27 2025-06-21 美商Ｆｃｉ美國有限責任公司 High speed, high density direct mate orthogonal connector

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999024578A2 (en) * 1997-11-06 1999-05-20 Chiron S.P.A. Neisserial antigens

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6982320B2 (en) * 1998-03-19 2006-01-03 Human Genome Sciences, Inc. Cytokine receptor common gamma chain like
US6673910B1 (en) * 1999-04-08 2004-01-06 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics
US6632636B1 (en) 1999-06-18 2003-10-14 Elitra Pharmaceuticals Inc. Nucleic acids encoding 3-ketoacyl-ACP reductase from Moraxella catarrahalis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999024578A2 (en) * 1997-11-06 1999-05-20 Chiron S.P.A. Neisserial antigens

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MYERS, L.E. ET AL.: "The Transferrin Binding Protein B of Moraxella catarrhalis Elicits Bactericidal Antibodies and Is a Potential Vaccine Antigen", INFECTION AND IMMUNITY, vol. 66, no. 9, September 1998 (1998-09-01), pages 4183 - 4192, XP002118475 *

Also Published As

Publication number Publication date
HK1047954A1 (en) 2003-03-14
DK1204752T3 (en) 2008-10-20
ATE399205T1 (en) 2008-07-15
GB9918003D0 (en) 1999-09-29
CY1108554T1 (en) 2014-04-09
EP1204752B1 (en) 2008-06-25
AU6832300A (en) 2001-02-19
US20100075378A1 (en) 2010-03-25
DE60039303D1 (en) 2008-08-07
CA2380515A1 (en) 2001-02-08
ES2306668T3 (en) 2008-11-16
EP1204752A2 (en) 2002-05-15
PT1204752E (en) 2008-09-09
WO2001009332A2 (en) 2001-02-08
JP2003506043A (en) 2003-02-18
CN1378597A (en) 2002-11-06
US7632516B1 (en) 2009-12-15

Similar Documents

Publication Publication Date Title
WO1999058562A3 (en) Novel compounds
WO1999058684A3 (en) Compounds from moraxella catarrhalis
WO1999064602A3 (en) Moraxella catarrhalis polynucleotides and polypeptides
WO1999057277A3 (en) Basb019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
WO2000071724A3 (en) Novel compounds from moraxella catarrhalis
WO2001009332A3 (en) Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof
WO2002034768A3 (en) Polypeptides and polynucleodides from haemophilus influenzae and their use
PL345193A1 (en) Basb027 proteins and genes from moraxella catarrhalis
WO1999064448A3 (en) Moraxella catarrhalis pilq proteins
HK1047943A1 (en) Moraxella cattarrhalis basb114 antigens and uses thereof
HK1047956A1 (en) Basb118 polypeptide and polynucleotide from moraxella catarrhalis
WO2001009333A3 (en) Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof
WO1999058682A3 (en) Compounds from moraxella catarrhalis
WO2002030960A3 (en) Polypeptide from haemophilus influenza
WO2001009331A3 (en) Moraxella catarrhalis antigen basb125
WO2001009339A3 (en) Moraxella catarrhalis antigen basb117
WO2001023416A3 (en) Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof
WO2001009172A3 (en) Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof
WO2001009337A3 (en) Moraxella catarrhalis antigens basb122 and basb124
AU6988700A (en) Basb119 polypeptide and polynucleotide from moraxella catarrhalis
WO2001009330A3 (en) Moraxella catarrhalis antigen basb121
WO2001009335A3 (en) Moraxella catarrhalis antigen basb120
WO2001019862A3 (en) Polypeptides from moraxella (branhamella) catarrhalis
WO1999058685A3 (en) Basb028 polypeptides and polynucleotides encoding therefor from moraxella catarrhalis
WO2001019997A3 (en) BASB128 polypeptide and polynucleotide from moxarella catarrhalis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2000956339

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10048574

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2380515

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 008111049

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 2000956339

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 2000956339

Country of ref document: EP